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Abstract: DNA-based coatings possess beneﬁcial proper-
ties useful for medical and dental implants. The present
study evaluated the potential in vivo bioactivity of DNA-
based coatings, either or not pretreated in simulated body
ﬂuid (SBF). DNA-based coatings were generated on tita-
nium cylinders using layer-by-layer deposition, with bis-
ureido-surfactant as the cationic component and DNA as
the anionic component. Noncoated titanium implants and
CaP-coated implants served as controls. A total of 80
implants, divided in four experimental groups (n 5 10)
were implanted unilaterally into the lateral femoral con-
dyles of 80 rats. After implantation periods of 1 and 4 weeks,
the bone-to-implant contact and bone volume around the
implants were determined histomorphometrically. The
results of this study showed that DNA-based coatings and
CaP coatings increased bone-to-implant contact after 1 week
compared to noncoated controls. After 4 weeks of implanta-
tion, bone-to-implant contact increased signiﬁcantly for SBF
pretreated DNA coatings and CaP coatings, whereas DNA-
coated implants showed no additional effect. The bone-to-
implant contact of noncoated controls increased to the level
of the DNA-coated implants. Consequently, this study dem-
onstrates that DNA-based coatings are histocompatible and
favor early bone responses. SBF-pretreated DNA-based
coatings were found to increase both early and late peri-
implant bone responses.  2009 Wiley Periodicals, Inc.
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INTRODUCTION
In the ﬁeld of implantology, a wide variety of mate-
rials are used to generate biomedical devices with sat-
isfactory properties to replace body parts that have
been damaged or lost. Many types of metals (or metal-
lic alloys), ceramics, and polymers, or combinations
thereof, have been used for the construction of medi-
cal and dental implants.1 Commercially pure titanium
(Ti) is one of the most widely used materials for man-
ufacturing load-bearing implants. The use of titanium
for bone implants is based on the combination of
mechanical properties and corrosion resistance.2
However, as metals usually do not show bioactive
behavior, that is, they do not form a direct bond
between the implant and the surrounding bone tissue,
methods have been sought to improve the biological
contact at the implant/tissue interface. Consequently,
bioactive materials, such as calcium phosphate (CaP)
ceramics, have been routinely applied as thin coatings
onto metallic substrates to combine the mechanical
properties of the metal with the excellent biological
properties of CaP ceramics.3,4
Various deposition techniques have been used to
apply CaP coatings onto implants, of which plasma-
spraying and magnetron sputtering are the most
widely used. Although the osteoconductive and bio-
active properties of CaP coatings derived with these
techniques have been conﬁrmed by numerous stud-
ies,5,6 these coating methods still have important lim-
itations. For instance, both techniques are associated
with extremely high temperatures for post-treatment
of the coatings to transform the as-deposited amor-
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phous coatings into a crystalline phase. This makes
the incorporation of biologically active compounds
(e.g. growth factors) impossible. In addition, inherent
to both line-of-sight techniques is that only simple
(nonporous) 2D objects can be provided with a CaP
coating. In the ﬁeld of regenerative medicine, for
example, in craniofacial skeletal reconstructions,
however, scaffolds must ﬁt very complex three-
dimensional (3D) anatomic defects.7
To overcome these limitations, studies have been
undertaken to ﬁnd methods to increase surface bio-
activity. As proposed by Kokubo and Takadama,8
immersion of materials in simulated body ﬂuids
(SBF), which are solutions that are compositionally
similar to human blood plasma, is a well-deﬁned
method to obtain predictive information on the
materials in vivo bone-like apatite formation on the
implant surface. With the use of SBF in in vitro
experiments, in which in vivo apatite formation can
be mimicked, it has been demonstrated that nega-
tively charged groups, that is, phosphate-containing
groups in particular, are the most potent inducers of
the CaP nucleation process.9
In view of the aforementioned ﬁndings, a recently
proposed implant coating with deoxyribose nucleic
acid (DNA) as its main component has shown favor-
able CaP nucleation in comparison with titanium con-
trol.10 The idea behind the DNA-based coatings is
that, irrespective of its genetic information, DNA has
beneﬁcial biomaterial properties, which include non-
or low immunogenicity, capability to bind other bio-
logically active compounds (e.g., proteins or antibiot-
ics), and a high phosphate content. In view of these
properties, van den Beucken et al. fabricated and char-
acterized multilayered DNA-based coatings for bio-
material purposes, whose generation is based on the
layer-by-layer (LbL) deposition technique.11 This tech-
nique has been used previously for the generation of
various biomedical coatings which have been tested
in rat animal models.12–14 The results of these in vivo
experiments have demonstrated prolonged stability
(up to 3 months) at different implantation sites. The
multilayered DNA-based coatings further demon-
strated to be cyto- and histocompatible,15 and eligible
for functionalization with growth factors.16,17 The ear-
lier mentioned positive effect of phosphate-containing
groups on the CaP nucleation process, was also
observed for DNA-based coatings in comparison with
titanium in an SBF-soaking experiment. In addition,
SBF-pretreated DNA-based coatings affected the
differentiation of osteoblast-like cells through an
increased deposition of osteocalcin.10 The results of
this in vitro study are indicative for bone-bonding
capacities of DNA-based coatings, though conclusive
data on in vivo bioactivity are lacking.
In the present study, originally used cationic poly-
electrolytes for the generation of DNA-based coat-
ings were replaced by Bis-Ureido-Surfactant (BUS).
This surfactant molecule functions by the formation
of strong hydrogen bonds resulting in well-deﬁned
highly ordered ribbon-like bilayer aggregates,18
ensuring the presence of DNA at the surface.
Consequently, the present study aimed at evaluat-
ing the potential in vivo bioactivity of BUS/DNA
coatings, either or not pretreated in SBF. For this
purpose, BUS/DNA coatings were prepared on tita-
nium cylinders. Noncoated titanium cylinders served
as negative controls, whereas titanium cylinders
with a CaP-sputter coating served as positive con-
trols. The surfaces of all implant types were eval-
uated morphologically and physicochemically before
initiation of the in vivo implantation study. For the
in vivo experiment, the four types of implants were
inserted into the lateral femoral condyle of rats for
1 and 4 weeks to determine the osteogenic response,




Polyanionic salmon DNA (6 300 bp/molecules; sodium
salt) was kindly provided by Nichiro Corporation (Kawa-
saki-city, Kanagawa prefecture, Japan). BUS (Bis-Ureido-
Surfactant) was kindly provided by Dr. Nico Sommerdijk
and Dr. Matthijn Vos (Laboratory for Macromolecular and
Organic Chemistry, Eindhoven University of Technology,
The Netherlands).
Implant preparation and cleaning
Eighty cylindrical titanium implants (diameter: 1.75 mm;
length: 3.5 mm; commercially-pure titanium) were used.
Prior to coating deposition, implants were cleaned ultra-
sonically in nitric acid 10% (15 min), acetone (15 min), and
isopropanol (15 min), respectively. Subsequently, the
implants were air-dried.
Coating generation
The implants were left uncoated or provided with either
a multilayered DNA-coating or a CaP sputter coating.
LbL deposition of multilayered DNA coatings
Multilayered DNA coatings were generated using the
LbL deposition technique with BUS18 as the cationic com-
ponent and DNA as the anionic component. Brieﬂy, the
cleaned implants were immersed in an aqueous solution of
BUS (5 mg/mL) for 30 min, thereby allowing sufﬁcient
time for the adsorption of BUS (the ﬁrst cationic polyelec-
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trolyte layer) onto the implants. Subsequently, implants
were washed in ultra-pure water. Thereafter, substrates
were immersed alternately in an anionic aqueous DNA
solution (1 mg/mL), and a BUS solution (1 mg/mL) for
7 min each, with intermediate washing in ultra-pure water
(5 min; continuous water ﬂow). The build-up of the multi-
layered DNA-coatings was continued until a total of
5 double-layers was reached with a ﬁnal coating architec-
ture of [BUS/DNA]5 (the number indicates the total num-
ber of double layers).
Deposition of CaP sputter coatings
Prior to CaP coating deposition, implants were grit-
blasted with Al2O3 (Ra 5 0.8–1.0 lm). Subsequently, the
CaP coatings were deposited using a commercially avail-
able RF magnetron sputter unit (Edwards ESM 100) as
described previously by Wolke et al.19 The process pres-
sure was 5 3 1023 mbar and the sputter power 400 W.
Resultant coating thickness was 2.0 lm. After deposition,
all coated implants were subjected to an additional heat
treatment for 2 h at 5508C in a chamber furnace (UAF,
Lenton, Hope Valley, England).
SBF pretreatment of DNA-based coatings
The recipe for the preparation of SBF was adopted from
Kokubo and Takadama.8 Pre-treatment of the DNA-coated
implants was performed with SBF containing a 2-fold
increased calcium- and phosphate-ion concentration (SBF2)
compared to human blood plasma. Brieﬂy, chemicals were
dissolved in sequence into distilled water, one by one to
prevent precipitation in the solution during preparation.
After complete dissolution of the reagents, pH-value was
set at 7.4. Immersion studies were performed in 15-mL
tubes (Greiner Bio-One B.V., Alphen aan de Rijn, The
Netherlands), using 1 implant per tube in 4 mL SBF. Tubes
were placed in a water bath at 378C under continuous
shaking. The SBF solution was refreshed on a weekly
basis. After an immersion period of 2 weeks, implants
were thoroughly rinsed (3 times) with ultra-pure water,
and air-dried.
Surface morphology
Scanning electron microscopy (SEM) was performed to
examine the surface morphology of the implants. There-
fore, the substrates were sputter coated with gold and
examined using a Jeol 6310 scanning electron microscope
at an acceleration voltage of 10–15 kV (SEM; Jeol 6310,
Tokyo, Japan).
Surface analysis
The crystallographic structure of depositions on the sub-
strates was characterized using a Philips thin ﬁlm X-ray
diffractometer with CuKa-radiation (XRD; PW3710,
Almelo, The Netherlands). In addition, average surface
roughness values (Ra) were determined using a Universal
Surface Tester (UST; Innowep, Wurzburg, Germany).
Experimental animal groups
In the animal study, a total of four different experimen-
tal groups were used:
1 Ti, noncoated
2 Ti þ [BUS/DNA]5
3 Ti þ [BUS/DNA]5 þ SBF
4 Ti þ CaP
Sterility was obtained through autoclavation of non-
coated and CaP-coated implants. Generation of the DNA-
coating was performed under aseptic conditions after auto-
clavation of cleaned implants.
Surgical procedure
All in vivo work was conducted in accordance with ISO
standards, and protocols of the Central Animal Facility
(CDL; Radboud University Nijmegen Medical Center,
Nijmegen, The Netherlands). National guidelines for the
care and use of laboratory animals were observed, and
approval of the Experimental Animal Ethical Committee
was obtained. A total of 80 implants (10 implants per
experimental group for each implantation period; n 5 10)
were implanted unilaterally into 80 male Wistar rats
(1 implant per rat), with a mean body weight of about 250 g.
Surgery was performed under general inhalation anesthesia,
and sterile conditions. To reduce the postoperative pain,
Rimadyl1 (5.0 mg/kg) and Morphine1 (1.0 mg/kg) were
administered subcutaneously pre-operative. Before the
insertion of the implants, each animal was immobilized on
its back, and the hind limbs were shaved, washed, and dis-
infected with povidone-iodine. For implantation of the
implant in the femur, a longitudinal incision was made over
the patella. By ﬂexion of the knee joint, and shifting aside of
the patellar ligament, both femoral condyles were fully
exposed. After exposure of the condyles a hole with a diam-
eter of 1.75 mm was drilled using a dental bur (Elcomed
100, W&H Dentalwerk Burmoos, Austria) in the lateral fem-
oral condyle of either the right or the left limb, according to
statistic randomization. The bone defect preparation was
performed with a gentle surgical technique, using low rota-
tional drill speeds (800–1200 rpm), and continuous external
cooling with saline. In this way, one hole was made on the
lateral side of the condyle, resulting in one implant site per
rat. After preparation, the hole was irrigated and the
implant inserted (Fig. 1). After insertion of the implants, the
soft tissues were closed with resorbable sutures (Vicryl1
40; Ethicon Products, Amersfoort, The Netherlands), and
the skin with skin staples (Agraves; InstruVet, Cuijk, The
Netherlands). To reduce postoperative pain, all rats received
one subcutaneous injection with Temgesic1 (20lg/kg) and
Rimadyl1 for 2 days postoperatively. After both 1 and
4 weeks postimplantation, 40 rats were euthanized by an
overdose of CO2, and the implants with surrounding tissue
were retrieved for histological evaluation.
IN VIVO BIOACTIVITY OF DNA-BASED COATINGS 933
Journal of Biomedical Materials Research Part A
Histological preparations
After the animals were sacriﬁced, the femoral condyles
were retrieved, excess tissue was removed, and using a
diamond circular saw, the condyles were divided into
smaller specimens suitable for histological processing. Sub-
sequently, the tissue blocks were ﬁxed in 10% neutral buf-
fered formalin solution, dehydrated in a graded series of
ethanol (70–100%), washed with acetone, and embedded in
methyl methacrylate (MMA) for 4 weeks. After polymer-
ization, nondecalciﬁed thin sections, cross-sectional to the
axis of the implants, were prepared (at least 3 of each
implant), using a modiﬁed sawing microtome technique20
and stained with methylene blue and basic fuchsin.
Histological and histomorphometrical evaluation
To evaluate the trabecular bone response to the implants,
histological and histomorphometrical analyses were per-
formed. Histological evaluation using a light microscope
DMRD (Leica Microsystems AG, Wetzlar, Germany) con-
sisted of a concise description of the observed tissues reac-
tion, including the structure and arrangement of cells,
implant, and tissue-implant interface. In addition, a com-
puter-based image analysis technique (Leica Qwin Pro-
image analysis software; Leica Imaging Systems, Cam-
bridge, UK) was used for histomorphometrical evaluation.
The quantitative measurement was performed for three dif-
ferent sections per implant. The average of these three meas-
urements was used for statistical analysis. The quantitative
parameters assessed were bone-implant contact and bone
volume (at magniﬁcation 253). The amount of bone contact
was deﬁned as the percentage of implant length at which
there is direct bone-to-implant contact. In cross-sectional
histological sections, the implant edge was selected man-
ually after which the bone in direct contact with the implant
edge was determined as a percentage of the circumference
of the implant. To determine the amount of bone volume, a
circle with a diameter of 2.25 mm (ROI) was centered over
the implant. Subsequently, the implant area was measured
(IA), which was subtracted from the ROI, yielding the area
of interest (AOI). Thereafter, the amount of bone tissue in
the AOI was selected manually and deﬁned as the percent-
age of the AOI, yielding the deﬁnite amount of bone volume
per implant.
Statistical analysis
Statistical analyses of the surface roughness values (Ra),
bone-implant contact, and bone volume measurements
were performed using GraphPad Instat, version 3.0
(GraphPad Software, San Diego, CA). Statistical compari-
sons for roughness, bone implant contact, and bone vol-
ume of the four different experimental groups were per-
formed using a one-way ANOVA, combined with a post
hoc Tukey-Kramer Multiple Comparisons Test. Addition-
Figure 1. A (left): Location of implant site in the lateral femoral condyle. The black bar represents the implant. B (right):
Titanium cylinder inserted in the lateral femoral condyle of a rat. [Color ﬁgure can be viewed in the online issue, which is
available at www.interscience.wiley.com.]
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ally, statistical comparisons for each experimental group
between the two implantation periods (week 1–week 4)
were performed using an unpaired t-test. Data shown are
means þ SD. The signiﬁcance level was set at a probability
(p) value smaller than 0.05.
RESULTS
Surface analysis and morphology
The XRD analyses of the heat-treated (5508C) sput-
ter coating revealed a crystalline CaP coating with
mean diffraction peaks of apatitic calcium phosphate
at 2u 5 25.98 (002), 31.98 (211), 32.48 (112), 33.28
(300), and 34.08 (202). Analyses of the [BUS/DNA]5
þ SBF substrates revealed a poorly crystalline apa-
titic nature with diffraction peaks at 2u 5 25.98 (002),
and 31.98 (211), (data not shown).
The results of the surface roughness measure-
ments and the outcome of the statistical analyses are
depicted in Table I. The surfaces of the different
experimental implants had an average surface rough-
ness value (Ra) of 0.16, 0.21, 0.25, and 1.47 for non-
coated controls, [BUS/DNA]5, [BUS/DNA]5 þ SBF,
and CaP, respectively. In comparison with the non-
coated controls, statistically signiﬁcant differences
were observed for [BUS/DNA]5 þ SBF (p < 0.05) and
CaP (p < 0.001). Additionally, the surface roughness
of CaP was signiﬁcantly higher compared to both
[BUS/DNA]5 and [BUS/DNA]5 þ SBF (p < 0.001).
Scanning electron micrographs of the different
experimental implant surfaces, showed apparent dif-
ferences between all experimental groups (Fig. 2).
Images of the noncoated controls showed the origi-
nal surface morphology of as-machined Ti. Observa-
tion of the [BUS/DNA]5-coated surfaces with low
magniﬁcation (7503) did not show the presence of
the deposited DNA-based coating. At higher magni-
ﬁcation (75003), however, a uniform surface layer
was observed on the implant surface. Immersion in
SBF for 2 weeks resulted in granular depositions of
different sizes (ranging from 1–3 lm) over the
entire surface of the [BUS/DNA]5 þ SBF-coated
implants. High magniﬁcation SEM images revealed
that each granule consisted of a large number of tiny
ﬂake-like crystals. SEM observations of the magne-
tron sputter-coated CaP implants showed a continu-
ous surface coverage with a rough appearance com-
pared to the other surface modiﬁcations.
Implant retrieval
All 80 rats remained in good health during the ex-
perimental period without any postoperative wound
healing complications. At sacriﬁce, no signs of
inﬂammation or adverse tissue reaction could be
seen around the implants. Table II depicts the num-
ber of implants placed, retrieved after implantation,
and included in the histological and histomorpho-
metrical analyses. Of the 80 installed implants, a
total of 79 implants could be retrieved. One implant
([BUS/DNA]5 þ SBF) was not found during re-
trieval.
Descriptive histological evaluation
After an implantation period of 1 week, light
microscopic examination of the methylene blue/
basic fuchsin-stained sections of the implants and
their surrounding tissue demonstrated variable
amounts of new bone formation between implants
from different experimental groups (Fig. 3). In gen-
eral, little or no inﬂammatory cells, such as macro-
phages and foreign body giant cells were observed
and only occasionally an intervening ﬁbrous tissue
layer was present between the bone and the
implant. In most sections, the drilling procedure
appeared to have been accurate. In addition, dam-
age caused by the drilling procedure was only lim-
ited, evidenced by the absence of drilling debris
and/or fractured bone chips. In 1 implant (CaP),
the remains of an hemorrhage were present. Sev-
eral implants showed the presence of bone marrow
or growth plate at the original defect site limiting
the amount of bone surrounding the implant. Fur-
thermore, the diameter of the implant bed was
occasionally oversized in relation to the implant
diameter, resulting in little or no bone-to-implant
contact. In all other implants, a close bone-to-
implant contact was observed.
After 4 weeks of implantation, the histological sec-
tions generally demonstrated an increase in new
bone formation. Similarly to week 1, little or no
TABLE I
Determination of Surface Roughness
Experimental Surface Ra (lm 6 SD)
Noncoated (Titanium) 0.16 6 0.01
[BUS/DNA]5 0.21 6 0.02
[BUS/DNA]5 þ SBF 0.25 6 0.01*
CaP 1.47 6 0.07***
Ra, surface roughness.
Statistical analyses were performed using a one-way
ANOVA, combined with a post hoc Tukey-Kramer multi-
ple comparisons test.
*Signiﬁcantly increased surface roughness compared to
noncoated controls (p < 0.05).
***Signiﬁcantly increased surface roughness compared to
noncoated controls, [BUS/DNA]5 and [BUS/DNA]5 þ SBF
(p < 0.001).
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inﬂammatory cells were observed. Additionally, in
several sections bone marrow or growth plate was
present and again in a few sections the diameter of
the implant bed was oversized in relation to the
implant diameter. In all other implants a close bone-
to-implant contact was observed.
Figure 2. Scanning electron micrographs of cylindrical Ti implants with different surface modiﬁcations before implanta-
tion. Ti, noncoated control, [BUS/DNA]5, [BUS/DNA]5 þ SBF, and CaP. Note the ﬂake-like crystals at the surface of the
[BUS/DNA]5 þ SBF-coated implants at the high magniﬁcation image.
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Histomorphometrical analysis
The number of implants used for histomorphometri-
cal analyses is depicted in Table II. Several implants
were excluded for histomorphometrical analyses for dif-
ferent reasons: the presence of bone marrow or growth
plate at the defect site, or an oversized implant bed.
Bone-to-implant contact
The results of the bone-to-implant contact measure-
ments and the outcome of the statistical analyses are
depicted in Table III. A total of 56 implants were used
for bone-to-implant contact measurements. The data
illustrate that after an implantation period of 1 week,
the noncoated controls showed the statistically signiﬁ-
cant lowest bone-to-implant contact (13.1% 6 2.4%),
whereas [BUS/DNA]5, [BUS/DNA]5 þ SBF and CaP-
coated implants showed similar bone-to-implant con-
tact (21.3% 6 6.8%, 24.5% 6 5.3%, and 23.5% 6 5.0%,
respectively). After an implantation period of 4 weeks,
statistically higher bone-to-implant contact values
were found for both [BUS/DNA]5 þ SBF and CaP-
coated implants (41.2% 6 13.0%, and 49.6% 6 13.3%)
compared to noncoated controls as well as [BUS/
DNA]5-coated (23.8%6 8.3%, 21.8%6 3.2%) implants.
Additionally, statistical comparisons between week 1
and week 4 showed signiﬁcantly increased bone-to
implant contact values for noncoated controls, [BUS/
DNA]5 þ SBF and CaP-coated implants compared to
1 week, whereas bone-to-implant contact for the
[BUS/DNA]5 group remained constant.
Bone volume
For the bone volume measurements, a total of 53
implants were used, of which the results and statisti-
TABLE II





No. of Implants Used for
Histomorphometrical Analysis
BIC BV
Week 1 Week 4 Week 1 Week 4 Week 1 Week 4 Week 1 Week 4
Noncoated 10 10 10 10 6 8 6 8
[BUS/DNA]5 10 10 10 10 7 8 7 6
[BUS/DNA]5 þ SBF 10 10 10 9a 8 7 8 8
CaP 10 10 10 10 6 6 5 5
aOne [BUS/DNA]5 þ SBF implant was lost after retrieval.
Figure 3. Representative histological sections of cylindrical implants surrounded by bone after 1 and 4 weeks of implan-
tation in the femoral condyles of rats. 1–4 weeks: noncoated controls; 1–4 weeks: [BUS/DNA]5; 1–4 weeks: [BUS/DNA]5 þ
SBF; 1–4 weeks: CaP. [Color ﬁgure can be viewed in the online issue, which is available at www.interscience.wiley.com.]
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cal outcomes are depicted in Table III. The amount
of bone volume was determined in a zone of 0.50
mm [2.25 mm (ROI) 21.75 mm (implant ø)]. The
results showed that after 1 week the amount of bone
volume was signiﬁcantly higher for CaP-coated
implants compared to noncoated controls (64.7% 6
7.1%). After 4 weeks the percentage of bone volume
ranged from 60.5 to 67.6%. Statistical testing did not
show any signiﬁcant differences between the indi-
vidual experimental implant groups for week 4.
DISCUSSION
This study was initiated to evaluate the potential
in vivo bioactivity of DNA-based coatings, either or
not pre-treated in SBF, in a rat femoral condyle
model. Noncoated titanium implants and CaP sput-
ter-coated titanium implants served as negative and
positive controls, respectively. After implantation
periods of 1 and 4 weeks, the bone-to-implant con-
tact and amount of bone volume were determined
histomorphometrically. The results of this study
showed that DNA-based coatings, either or not pre-
treated in SBF, and CaP coatings increased the bone-
to-implant contact after 1 week compared to non-
coated controls. Four weeks of implantation further
increased the bone-to-implant contact for noncoated
controls, SBF pre-treated DNA-coatings, and CaP
coatings, whereas no additional increase in bone-to-
implant contact was observed for the DNA-coated
implants. Bone volume measurements did not show
any signiﬁcant differences between the individual
experimental implant groups at both 1 and 4 weeks
postimplantation.
Previous studies by van den Beucken et al. dem-
onstrated the feasibility of the use of multilayered
DNA-based coatings for biomaterial purposes, using
poly-D-lysine (PDL) and poly(allylamine hydrochlor-
ide) (PAH) as cationic components.11 Chemical char-
acterization of these [PDL/DNA] and [PAH/DNA]
ﬁlms, using XPS and contact angle measurements,
showed that the layers in the multilayered coating
are not completely separated, but can be regarded as
partly mixed.11 Several authors stated that the mix-
ing process is a consequence of diffusion of the poly-
electrolytes ‘‘in’’ and ‘‘out’’ of the ﬁlm during build
up of the multilayered coating, and has some impor-
tant limitations.21,22 In view of the current study, the
major limitation of polyelectrolyte diffusion is the
presentation of DNA at the surface of the coating.
Because of the diffusion and mixing process, the
amount of DNA in the DNA-terminated layer
decreases. Consequently, the beneﬁcial properties of
DNA as a functional biomaterial, that is, an optimal
availability of the phosphate groups at the implant
surface, cannot be fully exploited. Additionally, in
the absence of discrete layers, the process of incorpo-
ration of proteins, drugs, or other biologicals in pre-
determined layers will be hampered. To overcome
these problems, physical barriers can be placed
between the various components within a single
ﬁlm, to control the interlayer diffusion.23 In the pres-
ent study, Bis-Ureido-Surfactant (BUS) was used to
function as a barrier for the formation of a multi-
compartment coating. This surfactant molecule func-
tions by the formation of strong hydrogen bonds
resulting in well-deﬁned highly ordered ribbon-like
bilayer aggregates,18 ensuring the presence of DNA
at the surface. Apart from acting as a stabilizing
unit, bis-urea units can also be used as an anchor for
functional molecules, such as growth factors. By
using a spacer, these functional molecules will be
able to penetrate the surface layer of DNA and
become exposed on the surface.18 Therefore, by gen-
erating multilayered [BUS/DNA]-coatings the func-
tional properties of both the anionic DNA molecule
and the cationic counterpart, BUS, can be optimally
used.
In the present study, histological data demonstrated
that titanium implants deposited with multilayered
TABLE III
Bone-Implant Contact (%) and Bone Volume (%) (Mean 6 SD)
Bone-Implant Contact (%) Bone Volume (%)
Week 1 Week 4 Week 1 Week 4
Noncoated 13.1 6 2.4 23.8 6 8.3f 53.7 6 4.0 60.5 6 10.2
[BUS/DNA]5 21.3 6 6.8
a 21.8 6 3.2 57.8 6 4.0 63.4 6 6.8
[BUS/DNA]5þSBF 24.5 6 5.3b 41.2 6 13.0a,d,f 59.0 6 3.7 61.4 6 12.0
CaP 23.5 6 5.0a 49.6 6 13.3c,e,g 64.7 6 7.1b 67.6 6 9.5
Statistical analyses within week 1 and 4 were performed using a one-way ANOVA, combined with a post hoc Tukey-
Kramer multiple comparisons test. Between week 1 and 4 analyses were performed using an unpaired t-test.
Signiﬁcantly different compared to noncoated controls at each implantation period; ap < 0.05, bp < 0.01, cp < 0.001.
Signiﬁcantly different compared to [BUS/DNA]5 at each implantation period;
dp < 0.01, ep < 0.001.
Signiﬁcant difference within experimental group between week 1 and 4; fp < 0.05, gp < 0.01.
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[BUS/DNA] coatings and implanted in the femoral
condyles of rats, did not show any adverse tissue reac-
tions after 1 and 4 weeks of implantation. These
results indicate that [BUS/DNA] coatings can be
regarded as histocompatible. This observation corrob-
orates published data of other experiments, in which
DNA-coated implants or DNA-based biomaterials did
not show any unfavorable tissue responses after sub-
cutaneous implantation in the back of rats.15,24
With respect to histomorphometry, the results of
this study indicated that the presence of a multi-
layered [BUS/DNA] coating favored the initial bone-
implant contact. After 4 weeks of implantation, how-
ever, no additional effect on the peri-implant bone
response was observed. The reason for the absence of
an additional response in the DNA-coated group
remains unclear. In contrast, SBF pre-treated DNA-
coatings and CaP coatings showed both early and a
late positive effect on bone response compared to
noncoated controls. It can be hypothesized that this
observation might be partly due to the differences
in surface roughness between the individual experi-
mental groups. Numerous studies demonstrated
effects of surface roughness on the peri-implant bone
response25–31 and in vitro studies have shown that on
microrough surfaces, osteoblasts create a microen-
vironment favorable for new bone formation via a
decrease in osteoblast proliferation, and an increase in
differentiation and secretion of osteogenesis promot-
ing factors (such as TGF-b1).30,31 A systematic review
on animal studies by Shalabi et al., investigating the
effects of implant surface roughness on bone response
and implant ﬁxation after 12 weeks of implantation,
provided evidence for a positive relationship between
bone-to-implant contact and surface roughness.32 In
the present study, the positive controls, that is, the
CaP-coated implants, had a signiﬁcantly increased
roughness due to the necessity of grit-blasting prior to
CaP coating deposition through RF magnetron sput-
tering for coating adhesive reasons. However, it needs
to be emphasized that this experimental group, which
has demonstrated superior bone responses in previ-
ous animal experiments,33,34 served as positive con-
trol. To maximally diminish potential effects of differ-
ences in roughness on bone responses, the remaining
three experimental groups (noncoated controls,
[BUS/DNA] and [BUS/DNA] þ SBF) received no
conventional treatment to roughen the surface.
Regarding the relationship between bone-to-implant
contact and surface roughness, as described by
Shalabi et al., a positive correlation was found for SBF
pre-treated DNA-coated implants and CaP-coated
implants. Both groups showed a statistically higher
surface roughness and increased bone-to-implant
contact compared to noncoated controls. The DNA-
coated implants did not show a positive correlation,
though SBF pre-treated implants were only slightly,
but not signiﬁcantly rougher. Therefore, it is not likely
that the increased osteogenic response to SBF pre-
treated DNA-coatings is solely due to variations in
surface roughness.26 It can be further hypothesized
that this observation might be due to the presence of
CaP depositions on the DNA-coated implant surfaces
after immersion in SBF (Fig. 2). After all, the presence
of a biologically active bone-like apatite layer on an
implant surface enhances the formation of a tight
chemical bond between the bone apatite and surface
apatite, favoring the osteogenic response.4,35
Beside focusing on the importance of altering
implant surfaces to improve implant stability and
bone healing, another essential feature that needs
attention is the surgical implant procedure in rela-
tion to the animal implantation model. Although the
rat femoral condyle model is easy to perform,
requires little operation time and most important,
has a low inconvenience score for the animals, still
some important limitations are related to this model.
Histological evaluation showed that in several sec-
tions the implant diameter resembled the medio-
lateral diameter of the lateral condyle, resulting in
little or no bone tissue surrounding the implant.
Because of the limited dimension of the lateral con-
dyle, implants were placed in, or in contact with, the
growth plate or bone marrow cavity. In addition,
with respect to the small implant diameter, the
defect was easily drilled slightly oversized in rela-
tion to the implant diameter, resulting in little or no
bone-to-implant contact, or the presence of an inter-
vening ﬁbrous tissue layer. To overcome these prob-
lems, a suggestion would be to decrease the implant
diameter, to switch to a bigger animal model, or to
place the implants in a different implantation loca-
tion, such as the intramedullary cavity36 or different
implant orientation, that is, from medial to lateral37
(instead of from distal to proximal as performed in
the present study).
In summary, this study demonstrates that DNA-
based coatings are histocompatible and favor the
early bone response. SBF-pretreated DNA-based
coatings were found to increase both the early and
the late peri-implant bone response.
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